Search
for
Sort by
Research 331–360 of 1000+
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell
- Broussonetia papyrifera Promotes Hair Growth Through the Regulation of β-Catenin and STAT6 Target Proteins: A Phototrichogram Analysis of Clinical Samples
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- Hedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Advance Understanding and New Treatment of Alopecia Areata
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Exploring novel management options for alopecia areata
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Alopecia areata: medical treatments
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- A systematic review on the treatment of androgenetic alopecia
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- A review of Janus kinase inhibitor use in scarring alopecia
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Janus kinase inhibitors for alopecia areata: A narrative review
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides